Urology
Volume 63, Issue 1 , Pages 148-149 , January 2004

Editorial comment

References 

  1. Swanson D, Eschenbach A, Babaian R, et al: Is retroperitoneal lymph node dissection (RLND) alone optimal or sufficient therapy for clinical stage 1 nonseminomatous germ cell testicular tumours. J Urol 159 (Proc AUA suppl 5): 179, 1999
  2. van Leeuwen FE, Stiggelbout AM, Vandenbeltdusebout AW, et al.  Second tumours after radiation treatment of testicular germ-cell tumors. J Clin Oncol. 1993;11:2286–2287
  3. Freedman LS, Parkinson MC, Jones WG, et al.  MRC Testicular Tumour Subgroup (Urological Working Party)   Histopathology in the prediction of relapse of patients with stage 1 testicular teratoma treated by orchidectomy alone. Lancet. 1987;2:294–298
  4. Warde P, Specht L, Horwich A, et al.  Prognostic factors for relapse in stage I testicular seminoma managed by surveillance (a pooled analysis). J Clin Oncol. 2002;20:4448–4452
  5. Oliver RT, Edmonds PM, Ong JY, et al.  Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma (should it be tested in a randomized trial against radiotherapy?). Int J Radiat Oncol Biol Phys. 1994;29:3–8

PII: S0090-4295(03)01043-4

doi: 10.1016/j.urology.2003.08.046

Urology
Volume 63, Issue 1 , Pages 148-149 , January 2004

Article Tools